Vaccination Protocols & Guidance

Local Guidance & SOPs:

Primary Care Vaccination Site Vaccine Choice Policy V 1.0

PSDs (Patient Specific Directions for the Administration of COVID-19 Vaccines:

(PSD process notes to follow)

On Site Clinical Lead Guidance:
Information for Consenters:
COVID Vaccine Trial Participants – Guidance:

Process for Vaccinating COVID Vaccine Trial Participants V 1.0

Consent Support Information for Responsible Clinicians for Pfizer & AstraZeneca Vaccines:

Responsible Clinician Supporting Information V 3.2

Allergy Clinic Referral – Letter to Registered Practice Template:

Allergy Clinic form for LVS V 1.0

Specific Vaccination National Protocols:

Pfizer/BioNTech Vaccine:

Pfizer BioNTech National Protocol V 03.00 

AstraZeneca Vaccine:

AstraZeneca National Protocol V 02.00_with cover page April 21

National Guidance & SOPs:

COVID-19 Vaccination Programme FAQs on Second Dose

INCREASED FLEXIBILITY TO OFFER VACCINATION TO COHORTS 3 AND 4 Version 2_22.01.21

C1034 Vaccination Centre Operating Framework 8 January 2021

C1038-COVID-19-Vaccine-Deployment-in-Community-Settings-LVS-SOP-v3.2-14-January-2021

JCVI Guidance – Priority Groups – 6th Jan 2021

Legal mechanisms for administration of the COVID-19 Vaccine

C1039_System letter COVID-19 second dose_11jan21 (002)

Covid-19 Vaccination Scheduling and PHE Delivery and Surveillance Strategy:

PGDs for Pfizer/BionTech & AstraZeneca Vaccines:

C1013-patient-group-direction-summary-for-covid-19-vaccines-6-jan-2021

C0956-PfizerBioNTechCOVID-19PGD-v02.00-updated-5-January-2021 (1)Word Document

C1012-patient-group-direction-for-covid-19-vaccine-astra-zeneca-ChAdOx1-S-6-jan-2021 (2)Word Document

Pfizer Vaccine List of Excipients:

Pfizer Vaccine List of Excipients 210205

Pinnacle Information:

Pinnacle_Additional Information Questions for PoC Data Capture 26.01.21

Pinnacle Paper Backup Form V 1.1 (Includes Ethnicity Questions)

Patient Information Leaflets: